We have located links that may give you full text access.
Implant Survival in the Edentulous Jaw: 30 Years of Experience. Part II: A Retro-Prospective Multivariate Regression Analysis Related to Treated Arch and Implant Surface Roughness.
International Journal of Prosthodontics 2018 November
PURPOSE: To report retro-prospective, long-term data on the prevalence of implant failures related to maxillary and mandibular arches and to different implant surfaces in a large number of edentulous patients.
MATERIALS AND METHODS: Altogether, 3,493 and 1,092 edentulous arches were consecutively treated with implants with turned (1986-2002) or moderately rough (2003-2015) surfaces, respectively, during two time periods at one referral clinic. All implant failures were consecutively identified during routine follow-up, and a multivariate logistic regression analysis was performed to analyze implant failure related to arch and implant surface.
RESULTS: Overall cumulative survival rates (CSR) for arches treated with turned surface implants were 75.7% and 94.6% for the maxilla and mandible, respectively. The corresponding 10-year CSRs for arches treated with implants with a moderately rough surface were 91.9% and 96.1%, respectively. The strongest significant association (P < .05) with risk for implant failure was the maxilla, and this was more pronounced for implants with a turned surface. Age at surgery, implant surgeon, calendar year of surgery, and time of follow-up also had significant associations with risk of implant failure (P < .05).
CONCLUSION: Risk for implant failure was significantly higher for treatment in the maxilla, but this risk was decreased significantly when using implants with a moderately rough surface. The impact of surface was not so obvious for treatment in the mandible. Risk for late implant failures after the first year was lower for implants with a moderately rough surface in the maxilla, but this risk seemed to be comparable for the different surfaces in the mandible.
MATERIALS AND METHODS: Altogether, 3,493 and 1,092 edentulous arches were consecutively treated with implants with turned (1986-2002) or moderately rough (2003-2015) surfaces, respectively, during two time periods at one referral clinic. All implant failures were consecutively identified during routine follow-up, and a multivariate logistic regression analysis was performed to analyze implant failure related to arch and implant surface.
RESULTS: Overall cumulative survival rates (CSR) for arches treated with turned surface implants were 75.7% and 94.6% for the maxilla and mandible, respectively. The corresponding 10-year CSRs for arches treated with implants with a moderately rough surface were 91.9% and 96.1%, respectively. The strongest significant association (P < .05) with risk for implant failure was the maxilla, and this was more pronounced for implants with a turned surface. Age at surgery, implant surgeon, calendar year of surgery, and time of follow-up also had significant associations with risk of implant failure (P < .05).
CONCLUSION: Risk for implant failure was significantly higher for treatment in the maxilla, but this risk was decreased significantly when using implants with a moderately rough surface. The impact of surface was not so obvious for treatment in the mandible. Risk for late implant failures after the first year was lower for implants with a moderately rough surface in the maxilla, but this risk seemed to be comparable for the different surfaces in the mandible.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app